Report Categories
View AllRecent Articles
View All
Kalaris Therapeutics KLRS Rallies 436 as Bulls Target 516 20260520
Oxford Lane Capital Corp Reports Fiscal Year 2026 Fourth Quarter Results
Open Society Foundations Commits 300 Million to Strengthen US Economic Security and Civil Liberties
US Consumer Sentiment Remains Subdued Amid Inflation Geopolitical Conflicts and Trade Policy Uncertainty
CRVL Q1 2026 Earnings EPS of 061 Reported Stock Declines 285
MRAM Q1 2026 Earnings EPS Beats Estimates by 19 but Stock Declines on Missing Revenue Details
Fortis Inc FTS Q1 2026 Earnings EPS Slightly Misses Estimates Utility Operations Remain Stable
ASND Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Edge Lower
SMA Q1 2026 Earnings Earnings Per Share Surges 87 Above Expectations